The Produci Report was designed to provide pediatricians with up-to-date information on new medical equipment, office accessories, etc. Listings are made up from unsolicited press releases from the manufacturer They are neither advertisements nor endorsements
New St. Joseph Formulas for Children
Plough, Inc. introduces three innovative products from the trusted name in children's medications, St. Joseph*. The recently introduced products offer relief from symptoms of two common childhood ailments: colds and diarrhea.
St. Joseph Children's Anti-diarrheal. Forty percent of children 12 and younger suffer from diarrhea each year. For the first time, a product especially for children is available that is as effective as a leading prescription product, yet as safe and gentle as the leading over-thecounter products.
St. Joseph Nighttime Cold Relief for Children. What children often need most in recovering from a cold is a good night's sleep. New St. Joseph R Nighttime Cold Relief formula relieves all major cold and flu symptoms for four to six hours - and allows children to get their much-needed rest. St. Joseph* Nighttime Cold Relief is the only foursymptom cold relief product formulated especially for children. Four safe, effective ingrethents work together to relieve your child's cold symptoms.
St. Joseph Measured Dose Nasal Decongestant for Children. The ideal form of a children's medication is one that combines effectiveness with convenience. New St. Joseph" Measured Dose Nasal Decongestant is the first product designed especially for children that gives the same accurate, easy-to-use pump delivery system winning favor among adults.
These and other St. Joseph children's medications are available in drug, food, discount and mass merchandising stores throughout the country.
Cancer Treatment Video
Although cancer is the leading cause of death in children under 1 5, most childhood cancers today are curable - largely because of clinical research on acute lymphoblastic leukemia (ALL) over the past 20 years. The prognosis for this most common of childhood malignancies is now very positive, and it has served as a model for the research, diagnosis, and treatment of other, more resistant diseases in both children and adults.
ALL is the subject of a new videocassette, "The Most Common Childhood Malignancy," produced by the Network for Continuing Medical Education (NCME) and cosponsored for continuing education credit by the Albert Einstein College of Medicine of Yeshiva University. The program is available to 700 hospitals, medical centers, and medical schools in the US, Canada, and Japan.
Focusing on the ways ALL may present, the video highlights symptoms such as anemia, fever, unexplained pam, a high white blood cell count, hepatosplenomegaly lymphadenopathy, and thrombocytopenia. The video emphasizes thorough pediatric examinations, laboratory evaluations and bone marrow procedures, and the specifics of different treatment stages.
Physicians who participate in the continuing education activity can qualify for two credit hours in Category 1 of the Physicians Recognition Award of the American Medical Association or two Prescribed hours from the American Academy of Family Physicians.
For more information, contact The Network for Continuing Medical Education, One Harmon Plaza, Secaucus, NJ 07094; or call 201-867-3550.